Eli Lilly (LLY) Non Operating Interest Expenses (2009 - 2025)
Eli Lilly (LLY) recorded Non Operating Interest Expenses of $45.3 million in Q1 2012, down 1.1% from $45.8 million a year earlier and down 9.6% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Non Operating Interest Expenses (2009 - 2025) Analysis & Trends
On a TTM basis, Eli Lilly's Non Operating Interest Expenses came in at $185.5 million as of Mar 31, 2012, up 1.0% year-over-year; for FY2011, it came in at $186 million, up 0.3% from FY2010.
- Across earlier years, Non Operating Interest Expenses came in at $185.5 million in FY2010 (-29.0%) and $261.3 million in FY2009.
- Quarterly Non Operating Interest Expenses has ranged from $43.2 million in Q4 2010 to $64.3 million in Q2 2009 over the past five years.
- On a year-over-year basis, Non Operating Interest Expenses rose in 1 of the last six quarters, with an average decline of 4.1%.
- Per Business Quant, the preceding three quarters came in at $50.1 million (Q4 2011), $45 million (Q3 2011) and $45.1 million (Q2 2011).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 36.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 179.60 Mn |
| Jun 30, 2025 | 249.00 Mn |
| Mar 31, 2025 | 243.70 Mn |
| Dec 31, 2024 | 224.70 Mn |
| Sep 30, 2024 | 192.70 Mn |
| Jun 30, 2024 | 183.60 Mn |
| Mar 31, 2024 | 179.60 Mn |
| Mar 31, 2012 | 45.30 Mn |
| Dec 31, 2011 | 50.10 Mn |
| Sep 30, 2011 | 45.00 Mn |
| Jun 30, 2011 | 45.10 Mn |
| Mar 31, 2011 | 45.80 Mn |
| Dec 31, 2010 | 43.20 Mn |
| Sep 30, 2010 | 47.20 Mn |
| Jun 30, 2010 | 47.50 Mn |
| Mar 31, 2010 | 47.60 Mn |
| Jun 30, 2009 | 64.30 Mn |
API Access
Eli Lilly Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();